Flexomics

Flexomics is an early-stage biotech innovator building a unique functional genomics platform. Its core technology, centered on the FLEX picowell chip, enables researchers to culture, assay, and image live cells before performing single-cell RNA sequencing on the same sample, creating a direct link between cell behavior and molecular identity. The company, founded in 2020, operates as a private platform technology provider, securing non-dilutive funding through prestigious grants and industry partnerships to advance its tools for therapeutic discovery.

Integrated platform combining live-cell fluorescence imaging and single-cell RNA sequencing on a proprietary microfluidic picowell chip (FLEX chip). Enables 'Bring Your Own Assay' functional studies with direct linkage of phenotypic imaging data to transcriptomic profiles from the same individual cells.

Flexomics competes in the single-cell analysis space against large players like 10x Genomics, BD, and Standard BioTools, which focus primarily on sequencing or mass cytometry. Its unique differentiator is the seamless, on-chip integration of extended live-cell imaging prior to sequencing. It may also face competition from academic labs developing custom integrated methods and from companies specializing in high-content imaging or spatial genomics.